• 1
    Goodpasture EW. The significance of certain pulmonary lesions to the etiology of influenza. Am J Med Sci 1919; 158:86370.
  • 2
    Wilson CB, Dixon FJ. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 1973; 3:7489.
  • 3
    Saus J, Wieslander J, Langeveld JPM et al. Identification of the Goodpasture antigen as the α3 chain of collagen IV. J Biol Chem 1988; 263:1337480.
  • 4
    Turner N, Mason PJ, Brown R et al. Molecular cloning of the human Goodpasture antigen demonstrates it to be the α3 chain of type IV collagen. J Clin Invest 1992; 89:592601.
  • 5
    Ryan JJ, Mason PJ, Pusey CD et al. Recombinant α-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture antigen is critical for antibody binding. Clin Exp Immunol 1998; 113:1727.
  • 6
    Hellmark T, Segelmark M, Ungar C et al. Identification of the clinically relevant immunodominant region of collagen IV in Goodpasture's disease. Kidney Int 1999; 55:93644.
  • 7
    Netzer KO, Leinonen A, Boutaud A et al. The Goodpasture autoantigen: mapping the major conformational epitope(s) of alpha3(IV) collagen to residues 17–31 and 127–141 of the NC1 domain. J Biol Chem 1999; 274:11267274.
  • 8
    David M, Borza DB, Leinonen A et al. Hydrophobic amino acid residues are critical for the immunodominant epitope of the Goodpasture antigen. A molecular basis for the cryptic nature of the epitope. J Biol Chem 2001; 276:637077.
  • 9
    Sado Y, Okigaki T, Takamiya H et al. Experimental autoimmune glomerulonephritis with pulmonary haemorrhage in rats. The dose–effect relationship of the nephritogenic antigen from bovine glomerular basement membrane. J Clin Lab Immunol 1994; 15:199204.
  • 10
    Reynolds J, Mavromatidis K, Cashman SJ et al. Experimental autoimmune glomerulonephritis (EAG) induced by homologous and heterologous glomerular basement membrane in two sub-strains of Wistar Kyoto rat. Nephrol Dial Transpl 1998; 13:4452.
  • 11
    Kalluri R, Danoff TM, Okada H et al. Susceptibility to anti-glomerular basement membrane disease and Goodpasture's syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 1997; 100:226375.
  • 12
    Sado Y, Boutaud AA, Kagawa M et al. Induction of anti-GBM nephritis in rats by recombinant α3(IV) NC1 and α4(IV) NC1 of type IV collagen. Kidney Int 1998; 53:66471.
  • 13
    Ryan JJ, Reynolds J, Norgan VA et al. Expression and characterisation of recombinant rat α3(IV)NC1 and its use in the induction of experimental autoimmune glomerulonephritis. Nephrol Dial Transpl 2001; 16:25361.
  • 14
    Hopfer H, Maron R, Butzmann U et al. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J 2003; 17:86068.
  • 15
    Reynolds J, Moss J, Duda MA et al. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. J Pathol 2003; 200:11829.
  • 16
    Sado Y, Naito I, Okigaki T. Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from urine of nephritic rats. J Pathol 1989; 158:32532.
  • 17
    Kohda T, Okada S, Hayashi A et al. High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis. Kidney Int 2004; 66:17786.
  • 18
    Reynolds J, Albouainain A, Duda MA et al. Strain susceptibility to active induction and passive transfer of experimental autoimmune glomerulonephritis in the rat. Nephrol Dial Transpl 2006; 21:3398408.
  • 19
    Wu J, Hicks J, Ou C et al. Glomerulonephritis induced by recombinant collagen IV alpha 3 chain non-collagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism. J Immunol 2001; 167:238895.
  • 20
    Wu J, Hicks J, Borillo J et al. CD4+ T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002; 109:51725.
  • 21
    Walters G, Habib A-M, Reynolds J et al. Glomerular T cells are of restricted clonality and express multiple CDR3 motifs across different Vβ T cell receptor families in experimental autoimmune glomerulonephritis. Nephron Exp Nephrol 2004; 98:7181.
  • 22
    Reynolds J, Pusey CD. In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis. Clin Exp Immunol 1994; 95:12227.
  • 23
    Reynolds J, Norgan VA, Bhambra U et al. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2002; 13:35969.
  • 24
    Reynolds J, Tam FWK, Chandraker A et al. CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 2000; 105:64351.
  • 25
    Reynolds J, Khan SB, Allen AR et al. Blockade of the CD154-CD40 T cell costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int 2004; 66:144452.
  • 26
    Reynolds J, Pusey CD. Oral administration of glomerular basement membrane prevents the development of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2001; 12:6170.
  • 27
    Reynolds J, Prodromidi EI, Juggapah JK et al. Nasal administration of recombinant rat α3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2005; 16:135055.
  • 28
    Reynolds J, Haxby J, Juggapah JK et al. Immunodominant B and T cell epitope in experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2003; 14:633a [Abstract.
  • 29
    Luo AM, Fox JW, Chen L et al. Synthetic peptides of Goodpasture's antigen in anti-glomerular basement membrane nephritis in rats. J Lab Clin Med 2002; 139:30310.
  • 30
    Wu J, Borillo J, Glass WF et al. T-cell epitope of α3 chain of type IV collagen induces severe glomerulonephritis. Kidney Int 2003; 64:1292301.
  • 31
    Robertson J, Wu J, Ardens J et al. Activation of glomerular basement membrane-specific B cells in the renal draining lymph node after T cell-mediated glomerular injury. J Am Soc Nephrol 2005; 16:325663.
  • 32
    Robertson J, Wu J, Arends J et al. Characterization of the T-cell epitope that causes anti-GBM glomerulonephritis. Kidney Int 2005; 68:106170.
  • 33
    Bolton WK, Chen L, Hellmark T et al. Epitope spreading and autoimmune glomerulonephritis in rats induced by a T cell epitope of Goodpasture's antigen. J Am Soc Nephrol 2005; 16:265766.
  • 34
    Chen L, Hellmark T, Pedchenko V et al. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis. J Am Soc Nephrol 2006; 17:307681.
  • 35
    Arends J, Wu J, Borillo J et al. T cell epitope mimicry in anti-glomerular basement membrane disease. J Immunol 2006; 176:125258.
  • 36
    Cairns LS, Phelps RG, Bowie L et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol 2003; 14:280112.